Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement.

Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, Hüe S, Ternacle J, Mohty D, Monin JL, Derumeaux G, Radu C, Damy T.

ESC Heart Fail. 2019 Aug;6(4):649-657. doi: 10.1002/ehf2.12451. Epub 2019 May 21.

2.

Effect of hemoglobin N Baltimore on HbA1c measurement in six methods.

Ratnam C, Yen Tran Houangkeo TH, Moutereau S, Plantamura J, Sollier M, Garcia C, Delacour H.

Ann Biol Clin (Paris). 2019 Apr 1;77(2):155-159. doi: 10.1684/abc.2019.1427. Review.

PMID:
30998195
3.

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Bao EL, Lareau CA, Brugnara C, Fulcher IR, Barau C, Moutereau S, Habibi A, Badaoui B, Berkenou J, Bartolucci P, Galactéros F, Platt OS, Mahaney M, Sankaran VG.

Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.

PMID:
30680775
4.

Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats.

Hamdani S, Thiolat A, Naserian S, Grondin C, Moutereau S, Hulin A, Calderaro J, Grimbert P, Cohen JL, Azoulay D, Pilon C.

World J Gastroenterol. 2017 Oct 14;23(38):6962-6972. doi: 10.3748/wjg.v23.i38.6962.

5.

Prognostic Value of Relative Adrenal Insufficiency During Cardiogenic Shock: A Prospective Cohort Study With Long-Term Follow-Up.

Bagate F, Lellouche N, Lim P, Moutereau S, Razazi K, Carteaux G, de Prost N, Dubois-Randé JL, Brun-Buisson C, Mekontso Dessap A.

Shock. 2017 Jan;47(1):86-92.

PMID:
27984534
6.

Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.

Salem L, Saleh N, Désaméricq G, Youssov K, Dolbeau G, Cleret L, Bourhis ML, Azulay JP, Krystkowiak P, Verny C, Morin F, Moutereau S; French Huntington Study Group, Bachoud-Lévi AC, Maison P.

PLoS One. 2016 Sep 14;11(9):e0162890. doi: 10.1371/journal.pone.0162890. eCollection 2016.

7.

A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.

Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.

Am J Hematol. 2016 Dec;91(12):1181-1184. doi: 10.1002/ajh.24537. Epub 2016 Sep 7.

8.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

9.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

10.

First evidence of subclinical renal tubular injury during sickle-cell crisis.

Audard V, Moutereau S, Vandemelebrouck G, Habibi A, Khellaf M, Grimbert P, Levy Y, Loric S, Renaud B, Lang P, Godeau B, Galactéros F, Bartolucci P.

Orphanet J Rare Dis. 2014 Apr 29;9:67. doi: 10.1186/1750-1172-9-67.

11.

Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.

Damy T, Deux JF, Moutereau S, Guendouz S, Mohty D, Rappeneau S, Guellich A, Hittinger L, Loric S, Lefaucheur JP, Plante-Bordeneuve V.

Amyloid. 2013 Dec;20(4):212-20. doi: 10.3109/13506129.2013.825240. Epub 2013 Aug 21.

12.

COMMD1 modulates noxious inflammation in cystic fibrosis.

de Becdelièvre A, Rocca J, Aissat A, Drévillon L, Moutereau S, Le Gouvello S, Hinzpeter A, Tarze A, Fanen P.

Int J Biochem Cell Biol. 2013 Nov;45(11):2402-9. doi: 10.1016/j.biocel.2013.07.012. Epub 2013 Jul 24.

PMID:
23892095
13.

Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease.

Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen JP, Lefaucheur JP, Césaro P, d'Ortho MP, Drouot X.

Nat Sci Sleep. 2013 Jun 12;5:87-91. doi: 10.2147/NSS.S41245. Print 2013.

14.

Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.

J Crit Care. 2013 Oct;28(5):701-9. doi: 10.1016/j.jcrc.2013.03.007. Epub 2013 May 15.

PMID:
23683568
15.

Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.

Robach P, Recalcati S, Girelli D, Campostrini N, Kempf T, Wollert KC, Corbella M, Santambrogio P, Perbellini L, Brasse-Lagnel C, Christensen B, Moutereau S, Lundby C, Cairo G.

Eur J Haematol. 2013 Jul;91(1):74-84. doi: 10.1111/ejh.12122. Epub 2013 May 3.

PMID:
23582009
16.

Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).

Lim P, Moutereau S, Simon T, Gallet R, Probst V, Ferrieres J, Gueret P, Danchin N.

Am J Cardiol. 2013 Jan 1;111(1):31-7. doi: 10.1016/j.amjcard.2012.08.042. Epub 2012 Oct 9.

PMID:
23062316
17.

Hemolysis induced by an extreme mountain ultra-marathon is not associated with a decrease in total red blood cell volume.

Robach P, Boisson RC, Vincent L, Lundby C, Moutereau S, Gergelé L, Michel N, Duthil E, Féasson L, Millet GY.

Scand J Med Sci Sports. 2014 Feb;24(1):18-27. doi: 10.1111/j.1600-0838.2012.01481.x. Epub 2012 Jun 5.

PMID:
22672635
18.

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.

Durand X, Xylinas E, Radulescu C, Haus-Cheymol R, Moutereau S, Ploussard G, Forgues A, Robert G, Vacherot F, Loric S, Allory Y, Ruffion A, de la Taille A.

BJU Int. 2012 Jul;110(1):43-9. doi: 10.1111/j.1464-410X.2011.10682.x. Epub 2012 Jan 5.

19.

Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cells.

Sirab N, Terry S, Giton F, Caradec J, Chimingqi M, Moutereau S, Vacherot F, de la Taille A, Kouyoumdjian JC, Loric S.

Int J Cancer. 2012 Sep 15;131(6):1297-306. doi: 10.1002/ijc.27384. Epub 2012 Jan 27.

20.

Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD.

Drouot X, Moutereau S, Lefaucheur JP, Palfi S, Covali-Noroc A, Margarit L, Stoïca-Herman M, Nguyen JP, Césaro P, d'Ortho MP.

Sleep Med. 2011 Oct;12(9):936-7. doi: 10.1016/j.sleep.2011.08.002. Epub 2011 Oct 5. No abstract available.

PMID:
21978722
21.

A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells.

Prost à la Denise J, Dekairelle AF, Desbene C, Moutereau S, Douard R, Devanlay M, Eschwege P, Gala JL, Loric S.

Clin Chem Lab Med. 2011 Jun;49(6):1073-5. doi: 10.1515/CCLM.2011.175. No abstract available.

PMID:
21649554
22.

Progensa™ PCA3 test for prostate cancer.

Durand X, Moutereau S, Xylinas E, de la Taille A.

Expert Rev Mol Diagn. 2011 Mar;11(2):137-44. doi: 10.1586/erm.10.122.

PMID:
21405964
23.

Improved neopterin ELISA kit: a good compromise between HPLC results and clinical practice.

Moutereau S, Ech Chad N, Devanlay M, Esmilaire L, Loric S.

Clin Chem Lab Med. 2011 Mar;49(3):553-4. doi: 10.1515/CCLM.2011.071. Epub 2011 Feb 11. No abstract available.

PMID:
21309728
24.

[Testosterone assays using non recommended methods lead to misdiagnosis in women].

Taibi L, Giton F, Moutereau S, Fiet J, Guéchot J.

Ann Biol Clin (Paris). 2010 Nov-Dec;68(6):649-56. doi: 10.1684/abc.2010.0486. French.

25.

Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.

Ploussard G, Durand X, Xylinas E, Moutereau S, Radulescu C, Forgue A, Nicolaiew N, Terry S, Allory Y, Loric S, Salomon L, Vacherot F, de la Taille A.

Eur Urol. 2011 Mar;59(3):422-9. doi: 10.1016/j.eururo.2010.11.044. Epub 2010 Dec 8.

PMID:
21156337
26.

High insulinlike growth factor I is associated with cognitive decline in Huntington disease.

Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-Lévi AC, Maison P; Huntington French Speaking Group.

Neurology. 2010 Jul 6;75(1):57-63. doi: 10.1212/WNL.0b013e3181e62076. Erratum in: Neurology. 2010 Oct 12;75(15):1399.

PMID:
20603485
27.

'Desperate house genes': the dramatic example of hypoxia.

Caradec J, Sirab N, Keumeugni C, Moutereau S, Chimingqi M, Matar C, Revaud D, Bah M, Manivet P, Conti M, Loric S.

Br J Cancer. 2010 Mar 16;102(6):1037-43. doi: 10.1038/sj.bjc.6605573. Epub 2010 Feb 23.

28.

Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C.

Conti M, Moutereau S, Esmilaire L, Desbene C, Lallali K, Devanlay M, Durrbach A, Manivet P, Eschwège P, Loric S.

Clin Chem Lab Med. 2009;47(12):1553-6. doi: 10.1515/CCLM.2009.341.

PMID:
19877765
29.

Neuroendocrine disturbances in Huntington's disease.

Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-Lévi AC, Maison P.

PLoS One. 2009;4(3):e4962. doi: 10.1371/journal.pone.0004962. Epub 2009 Mar 25.

30.

Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ, Norgaard AM, Alberghini A, Campostrini N, Castagna A, Viganò A, Santambrogio P, Kempf T, Wollert KC, Moutereau S, Lundby C, Cairo G.

Blood. 2009 Jun 25;113(26):6707-15. doi: 10.1182/blood-2008-09-178095. Epub 2009 Mar 4.

31.

Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation.

Darmon M, Schortgen F, Leon R, Moutereau S, Mayaux J, Di Marco F, Devaquet J, Brun-Buisson C, Brochard L.

Intensive Care Med. 2009 Jun;35(6):1031-8. doi: 10.1007/s00134-008-1372-5. Epub 2009 Feb 26.

PMID:
19242676
32.

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.

Eschwège P, Moutereau S, Droupy S, Douard R, Gala JL, Benoit G, Conti M, Manivet P, Loric S.

Br J Cancer. 2009 Feb 24;100(4):608-10. doi: 10.1038/sj.bjc.6604912.

33.

Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.

Azoulay S, Terry S, Chimingqi M, Sirab N, Faucon H, Gil Diez de Medina S, Moutereau S, Maillé P, Soyeux P, Abbou C, Salomon L, Vacherot F, de La Taille A, Loric S, Allory Y.

J Pathol. 2008 Dec;216(4):460-70. doi: 10.1002/path.2427.

PMID:
18825689
34.

Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification.

Chiminqgi M, Moutereau S, Pernet P, Conti M, Barbu V, Lemant J, Sacko M, Vaubourdolle M, Loric S.

Clin Chem Lab Med. 2007;45(8):993-5.

PMID:
17867987
35.

Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction.

Lim P, Collet JP, Moutereau S, Guigui N, Mitchell-Heggs L, Loric S, Bernard M, Benhamed S, Montalescot G, Randé JL, Guéret P.

Clin Chem. 2007 Oct;53(10):1835-40. Epub 2007 Aug 16.

36.

Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle.

Robach P, Cairo G, Gelfi C, Bernuzzi F, Pilegaard H, Viganò A, Santambrogio P, Cerretelli P, Calbet JA, Moutereau S, Lundby C.

Blood. 2007 Jun 1;109(11):4724-31. Epub 2007 Feb 20.

37.

A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis.

Lemiale V, Renaud B, Moutereau S, N'Gako A, Salloum M, Calmettes MJ, Hervé J, Boraud C, Santin A, Grégo JC, Braconnier F, Roupie E.

Eur Urol. 2007 May;51(5):1394-401. Epub 2006 Dec 18.

PMID:
17207908
38.

Living high-training low: effect on erythropoiesis and maximal aerobic performance in elite Nordic skiers.

Robach P, Schmitt L, Brugniaux JV, Nicolet G, Duvallet A, Fouillot JP, Moutereau S, Lasne F, Pialoux V, Olsen NV, Richalet JP.

Eur J Appl Physiol. 2006 Aug;97(6):695-705. Epub 2006 Jun 20.

PMID:
16786355
39.

Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer.

Douard R, Moutereau S, Pernet P, Chimingqi M, Allory Y, Manivet P, Conti M, Vaubourdolle M, Cugnenc PH, Loric S.

Surgery. 2006 May;139(5):665-70.

PMID:
16701100
40.

Urinary cystatin C as a specific marker of tubular dysfunction.

Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, Eschwège P, Loric S.

Clin Chem Lab Med. 2006;44(3):288-91.

PMID:
16519600
41.

Living high-training low: effect on erythropoiesis and aerobic performance in highly-trained swimmers.

Robach P, Schmitt L, Brugniaux JV, Roels B, Millet G, Hellard P, Nicolet G, Duvallet A, Fouillot JP, Moutereau S, Lasne F, Pialoux V, Olsen NV, Richalet JP.

Eur J Appl Physiol. 2006 Mar;96(4):423-33. Epub 2005 Dec 3.

PMID:
16328191
42.

MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients.

Tchernitchko D, Moutereau S, Legendre M, Delahaye A, Cazeneuve C, Lacombe C, Grateau G, Amselem S.

Arthritis Rheum. 2005 Nov;52(11):3603-5.

43.

Eighteen days of "living high, training low" stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners.

Brugniaux JV, Schmitt L, Robach P, Nicolet G, Fouillot JP, Moutereau S, Lasne F, Pialoux V, Saas P, Chorvot MC, Cornolo J, Olsen NV, Richalet JP.

J Appl Physiol (1985). 2006 Jan;100(1):203-11. Epub 2005 Sep 22. Erratum in: J Appl Physiol. 2006 Apr;100(4):1435.

44.

Acetazolamide: a treatment for chronic mountain sickness.

Richalet JP, Rivera M, Bouchet P, Chirinos E, Onnen I, Petitjean O, Bienvenu A, Lasne F, Moutereau S, León-Velarde F.

Am J Respir Crit Care Med. 2005 Dec 1;172(11):1427-33. Epub 2005 Aug 26.

PMID:
16126936
45.

Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.

Cochen V, Arnulf I, Demeret S, Neulat ML, Gourlet V, Drouot X, Moutereau S, Derenne JP, Similowski T, Willer JC, Pierrot-Deseiligny C, Bolgert F.

Brain. 2005 Nov;128(Pt 11):2535-45. Epub 2005 Jul 6.

PMID:
16000335
46.

Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.

Douard R, Moutereau S, Serru V, Sales JP, Wind P, Cugnenc PH, Vaubourdolle M, Loric S.

Clin Chem Lab Med. 2005;43(2):127-32.

PMID:
15843204
47.

Re: "Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR".

Douard R, Moutereau S, Wind P, Berger A, Cugenec PH, Loric S.

Surgery. 2005 Jan;137(1):123. No abstract available.

PMID:
15614295
48.

Absence of circadian variations in urine cystatin C allows its use on urinary samples.

Conti M, Zater M, Lallali K, Durrbach A, Moutereau S, Manivet P, Eschwège P, Loric S.

Clin Chem. 2005 Jan;51(1):272-3. No abstract available.

49.

An improved electronic microarray-based diagnostic assay for identification of MEFV mutations.

Moutereau S, Narwa R, Matheron C, Vongmany N, Simon E, Goossens M.

Hum Mutat. 2004 Jun;23(6):621-8.

PMID:
15146467
50.

Low levels of ventricular CSF orexin/hypocretin in advanced PD.

Drouot X, Moutereau S, Nguyen JP, Lefaucheur JP, Créange A, Remy P, Goldenberg F, d'Ortho MP.

Neurology. 2003 Aug 26;61(4):540-3.

PMID:
12939433

Supplemental Content

Loading ...
Support Center